Literature DB >> 3403126

Major risk factors for cardiovascular disease mortality in adults: results from the Nutrition Canada Survey cohort.

R M Semenciw1, H I Morrison, Y Mao, H Johansen, J W Davies, D T Wigle.   

Abstract

The cardiovascular mortality experience of over 7000 Canadians ages 35-79 years free of self-reported heart disease or stroke who participated in the Nutrition Canada survey is presented. The effects of various risk factors on cardiovascular disease mortality were assessed using multivariate Poisson regression analyses. Factors associated with a significantly increased risk of dying included cigarette smoking, hypertension, diabetes and, for women, serum cholesterol. Relative risks were similar for those ages 35-64 years compared to those 65-79 years for diabetes but were higher among those 35-64 years for cigarette smoking, diastolic hypertension, obesity and serum cholesterol (females only). Individuals drinking three or more drinks daily had a relative risk of 3.18 for stroke. Population attributable risks for smoking, hypertension, elevated serum cholesterol and diabetes, respectively, were 47%, 21%, 7% and 8% for men and 10%, 21% 18% and 16% for women.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3403126     DOI: 10.1093/ije/17.2.317

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  14 in total

Review 1.  Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence?

Authors:  K A Payne; S Esmonde-White
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

2.  Risk behaviours and self rated health in Russia 1998.

Authors:  P Carlson
Journal:  J Epidemiol Community Health       Date:  2001-11       Impact factor: 3.710

3.  Overweight and stroke in the Whitehall study.

Authors:  R Shinton; M Shipley; G Rose
Journal:  J Epidemiol Community Health       Date:  1991-06       Impact factor: 3.710

4.  At-risk drinking in an HMO primary care sample: prevalence and health policy implications.

Authors:  M F Fleming; L B Manwell; K L Barry; K Johnson
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

5.  Status Report--Retracing the history of the early development of national chronic disease surveillance in Canada and the major role of the Laboratory Centre for Disease Control (LCDC) from 1972 to 2000.

Authors:  B C K Choi; D T Wigle; H Johansen; J Losos; M E Fair; E Napke; L J Anderson; J W Davies; K White; A B Miller; F C K Li; S Stachenko; J Lindsay; L A Gaudette; C Nair; I Levy; H Morrison; J Silins; F Bouchard; L Tonmyr; P J Villeneuve; L McRae; K C Johnson; R S Lane; A Probert
Journal:  Health Promot Chronic Dis Prev Can       Date:  2015-04       Impact factor: 3.240

6.  Screening for hypercholesterolemia among Canadians: how much will it cost?

Authors:  S A Grover; L Coupal; R Fahkry; S Suissa
Journal:  CMAJ       Date:  1991-01-15       Impact factor: 8.262

7.  Prevalence of Self-reported Cardiovascular Risk Factors among Saudi Physicians: A Comparative Study.

Authors:  Ibrahim Al Alwan; Motasim Badri; Maram Al-Ghamdi; Alanoud Aljarbou; Hessa Alotaibi; Hani Tamim
Journal:  Int J Health Sci (Qassim)       Date:  2013-01

8.  Heart disease risk factors in midlife predict subclinical coronary atherosclerosis more than 25 years later in survivors without clinical heart disease: the Rancho Bernardo Study.

Authors:  Elizabeth Barrett-Connor; Jacqueline Bergstrom; Michael Wright; Caroline K Kramer
Journal:  J Am Geriatr Soc       Date:  2009-06       Impact factor: 5.562

9.  Body fat and stroke: unmasking the hazards of overweight and obesity.

Authors:  R Shinton; G Sagar; G Beevers
Journal:  J Epidemiol Community Health       Date:  1995-06       Impact factor: 3.710

10.  The design of an observational study of hypertension management, adherence and pressure control in Blood Pressure Success Zone Program participants.

Authors:  K A Payne; J J Caro; W L Daley; Z M Khan; K J Ishak; K Stark; D Purkayastha; J Flack; E Velázquez; S Nesbitt; D Morisky; R Califf
Journal:  Int J Clin Pract       Date:  2008-07-21       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.